Skip to main content
. 2021 Sep 11;40:101124. doi: 10.1016/j.eclinm.2021.101124

Table 1.

Baseline Characteristics by Treatment Group (ITT Population).

Placebo ALRV5XR
(N = 23) (N = 23)
Sex
 Male 23 (100%) 23 (100%)
 Female 0 (0%) 0 (0%)
Age (years)
 Mean ( ± SD) 45·7 ( ± 12·9) 48·3 ( ± 7·9)
 Range 22–65 32–63
Anthropometrics
 Height (cm) 172·7 (170·3–185·5) 175·3 (170·5–177·8)
 Weight (kg) 80·2 (69·3–90·8) 81·4 (73·7–93·6)
 BMI (kg/m2) 25·1 (22·6–31·2) 27·1 (23·7–31·8)
 BP (mmHg) 128·3/84·1 ( ± 13·5/9·9) 128·1/84·4 ( ± 21·5/17·9)
Trichometry
 Terminal hair density (per cm2) 141·6 ( ± 66·2) 139·1 ( ± 68·6)
 Vellus hair density (per cm2) 139·2 ( ± 62·2) 123·7 ( ± 66·2)
Ethnicity
 African American 4 (17·4%) 4 (17·4%)
 Caucasian 10 (43·5%) 7 (30·4%)
 Chinese 5 (21·7%) 6 (26·1%)
 Hispanic 1 (4·3%) 3 (13%)
 Indian 1 (4·3%) 0 (0%)
 Filipino 0 (0%) 1 (4·3%)
 Korean 1 (4·3%) 0 (0%)
 Mongolian 0 (0%) 1 (4·3%)
 Thai 0 (0%) 1 (4·3%)
 Vietnamese 1 (4·3%) 0 (0%)
Fitzpatrick Skin Type
 I 3 (13%) 1 (4·3%)
 II 3 (13%) 2 (8·7%)
 III 10 (43·5%) 15 (65·2%)
 IV 2 (8·7%) 1 (4·3%)
 V 2 (8·7%) 1 (4·3%)
 VI 2 (8·7%) 3 (13%)
 Unknown 1 (4·3%) 0 (0%)
Diagnosis
 AGA 23 (100%) 23 (100%)
 TE 0 (0%) 0 (0%)
Hamilton–Norwood Classification
 I 4 (17·4%) 0 (0%)
 II 2 (8·7%) 1 (4·3%)
 IIA 2 (8·7%) 1 (4·3%)
 III 1 (4·3%) (0%)
 IIIA 0 (0%) 1 (4·3%)
 IIIV 5 (21·7%) 6 (26·1%)
 IV 1 (4·3%) 4 (17·4%)
 V 0 (0%) 1 (4·3%)
 VA 3 (13%) 2 (8·7%)
 VI 1 (4·3%) 0 (0%)
 VII 2 (8·7%) 3 (13%)
 Missing 2 (8·7%) 4 (17·4%)

Abbreviations: ± or SD=standard deviation; † Height, Weight and BMI are reported as Median (IQR).